Skip to main content
Equibles
SKIN logo

SKIN · SkinHealth Systems Inc. · Earnings Call Transcripts & Audio

Track SKIN — free

Use SKIN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SKIN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.70 +0.01 (+1.45%) At close · Sep 11
Rebalance outlook locked
Market Cap
$91.10M
Shares
130.14M

SkinHealth Systems Inc. Earnings Call Transcripts

Quarterly earnings calls for SkinHealth Systems Inc. (SKIN), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲30.3% $88.79M −$81,000 '22 Q3 22-11-08 ▲26% $98.13M $6.53M '22 Q4 23-02-28 ▲14.4% $86.28M −$20.26M '23 Q1 23-05-10 ▲13.5% $117.48M $3.36M '23 Q2 23-08-09 ▲9.7% $97.41M −$73.82M '23 Q3 23-11-13 ▼1.3% $96.82M −$9.40M '23 Q4 24-03-12 ▼5.7% $81.40M −$679,000 '24 Q1 24-05-09 ▼22.9% $90.59M $202,000 '24 Q2 24-08-08 ▼19.1% $78.80M −$18.29M '24 Q3 24-11-12 ▼13.8% $83.50M −$10.33M '24 Q4 25-03-12 ▼14.5% $69.58M −$10.10M '25 Q1 25-05-08 ▼13.7% $78.19M $19.71M '25 Q2 25-08-07 ▼10.3% $70.66M −$11.03M '25 Q3 25-12-04 ▼1.3% $82.37M −$8.10M '25 Q4 26-03-12 ▼6.7% $64.91M −$6.63M '26 Q1 26-05-07 LATEST ▼7.8% $72.11M −$2.67M '26 Q2 26-08-06
Earnings call
FY26 · Q2
2026-08-06
SkinHealth Systems Inc. (SKIN) Q2 2026 Earnings Call
Balanced tone Hydrofacial Core Franchise Clinically Validated Boosters and Utilization Profitability and Margin Discipline
Revenue
$72.11M
▼ 7.8% YoY
Diluted EPS
$-0.02
▼ 166.7% YoY
Gross margin
68.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-07
SkinHealth Systems Inc. (SKIN) Q1 2026 Earnings Call Transcript
Cautious tone Consumables business Innovation pipeline Installed base and churn
Revenue
$64.91M
▼ 6.7% YoY
Diluted EPS
$-0.05
Gross margin
68.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-12
SkinHealth Systems Inc. (SKIN) Q4 2025 Earnings Call Transcript
Positive tone Consumables / boosters Installed base utilization shift Provider economics and commercial transformation
Revenue
$82.37M*
▼ 1.3% YoY
Gross margin
64.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-12-04
SkinHealth Systems Inc. (SKIN) Q3 2025 Earnings Call Transcript
Positive tone China distributor transition Macro and consumer weakness Churn in provider base
Revenue
$70.66M
▼ 10.3% YoY
Diluted EPS
$-0.09
Gross margin
64.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-07
SkinHealth Systems Inc. (SKIN) Q2 2025 Earnings Call Transcript
Confident tone Consumables and Razor-Razor Blade Model China Distributor Transition Margin Expansion and Cost Discipline
Revenue
$78.19M
▼ 13.7% YoY
Diluted EPS
$0.03
Gross margin
62.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-08
SkinHealth Systems Inc. (SKIN) Q1 2025 Earnings Call Transcript
Positive tone China distributor transition Consumables growth and recurring revenue Tariff exposure
Revenue
$69.58M
▼ 14.5% YoY
Diluted EPS
$-0.08
Gross margin
69.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-03-12
SkinHealth Systems Inc. (SKIN) Q4 2024 Earnings Call Transcript
Positive tone China distributor transition Consumables and boosters Cost discipline and profitability
Revenue
$83.50M*
▼ 13.8% YoY
Gross margin
62.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-12
SkinHealth Systems Inc. (SKIN) Q3 2024 Earnings Call Transcript
Balanced tone Consumables growth and gross margin Product innovation and HydraLoc HA Booster Macro headwinds and device sales pressure
Revenue
$78.80M
▼ 19.1% YoY
Diluted EPS
$-0.15
Gross margin
51.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-08
SkinHealth Systems Inc. (SKIN) Q2 2024 Earnings Call Transcript
Cautious tone Device sales recovery and capital equipment weakness Syndeo quality issues and replacement program Cost reduction and financial discipline
Revenue
$90.59M
▼ 22.9% YoY
Diluted EPS
$-0.10
▼ 433.3% YoY
Gross margin
45.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-09
SkinHealth Systems Inc. (SKIN) Q1 2024 Earnings Call Transcript
Positive tone Hydrafacial brand and provider relationships Guidance and financial outlook Syndeo device / capital equipment
Revenue
$81.40M
▼ 5.7% YoY
Diluted EPS
$-0.10
Gross margin
59.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-03-12
SkinHealth Systems Inc. (SKIN) Q4 2023 Earnings Call Transcript
Positive tone Provider and brand relationships Syndeo platform and quality issues Consumables growth and penetration
Revenue
$96.82M*
▼ 1.3% YoY
Gross margin
47.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-13
SkinHealth Systems Inc. (SKIN) Q3 2023 Earnings Call Transcript
Revenue
$97.41M
▲ 9.7% YoY
Diluted EPS
$-0.56
Gross margin
-12.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-09
SkinHealth Systems Inc. (SKIN) Q2 2023 Earnings Call Transcript
Revenue
$117.48M
▲ 13.5% YoY
Diluted EPS
$0.03
Gross margin
57.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-10
SkinHealth Systems Inc. (SKIN) Q1 2023 Earnings Call Transcript
Revenue
$86.28M
▲ 14.4% YoY
Diluted EPS
$-0.15
Gross margin
62.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-28
SkinHealth Systems Inc. (SKIN) Q4 2022 Earnings Call Transcript
Revenue
$98.13M*
▲ 26% YoY
Gross margin
67.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-08
SkinHealth Systems Inc. (SKIN) Q3 2022 Earnings Call Transcript
Revenue
$88.79M
▲ 30.3% YoY
Diluted EPS
$-0.03
Gross margin
69.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-09
SkinHealth Systems Inc. (SKIN) Q2 2022 Earnings Call Transcript
Revenue
$103.54M
▲ 55.7% YoY
Diluted EPS
$-0.06
Gross margin
67.6%
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-10
SkinHealth Systems Inc. (SKIN) Q1 2022 Earnings Call Transcript
Revenue
$75.42M
▲ 58.6% YoY
Diluted EPS
$-0.13
Gross margin
67.5%
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-22
SkinHealth Systems Inc. (SKIN) Q4 2021 Earnings Call Transcript
Revenue
$77.89M*
Gross margin
68.7%
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-09
SkinHealth Systems Inc. (SKIN) Q3 2021 Earnings Call Transcript
Revenue
$68.15M
▲ 97.2% YoY
Diluted EPS
$-1.63
Gross margin
67.6%
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-10
SkinHealth Systems Inc. (SKIN) Q2 2021 Earnings Call Transcript
Revenue
$66.51M
▲ 371.2% YoY
Diluted EPS
$-1.52
Gross margin
71.0%
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-13
SkinHealth Systems Inc. (SKIN) Q1 2021 Earnings Call Transcript
Revenue
$47.54M
Diluted EPS
$-0.09
Gross margin
66.8%
Rev · 3q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–22 of 22 earnings calls
Key facts CIK 1818093 CUSIP 88331L108 13F (30d) 37 filings 37 filers Visit website Investor relations